4basebio PLC (88Q.F)
4basebio PLC, engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally.
5.50+0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-49.1%
The outlook
4basebio PLC currently reads as bearish based on below its 50- & 200-day averages, 13% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range13% of the way from its 52-week low to high
Market cap
$85.2M
52-wk high
10.90
52-wk low
4.70
50-day avg
5.82
200-day avg
6.39
Trailing P/E
—